Adaptive Biotechnologies is a clinical research site located in Seattle, Washington, United States 98102.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Adaptive Biotechnologies has participated in 2 clinical trials.
Therapeutic areas: Covid19, Coronavirus Disease, SARS-CoV-2 Infection.
Sponsors: Adaptive Biotechnologies.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Adaptive Biotechnologies has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Adaptive Biotechnologies has 2 clinical trials on record. Their work covers Covid19, Coronavirus Disease, SARS-CoV-2 Infection.
Adaptive Biotechnologies has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.